Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 1

Status

Completed 3

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Lymphoma 113Leukemia 80Precursor Cell Lymphoblastic Leukemia-Lymphoma 61Lymphoma, Non-Hodgkin 59Multiple Myeloma 56Leukemia, Myeloid, Acute 56Lymphoma, Large B-Cell, Diffuse 55Hodgkin Disease 48Myelodysplastic Syndromes 43Burkitt Lymphoma 43Lymphoma, Follicular 41Leukemia, Lymphocytic, Chronic, B-Cell 41Lymphoma, Mantle-Cell 40Breast Neoplasms 35Lymphoma, Large-Cell, Immunoblastic 34Sarcoma 27Neoplasms, Plasma Cell 27Central Nervous System Neoplasms 25Lymphoma, B-Cell, Marginal Zone 24Dendritic Cell Sarcoma, Interdigitating 19Recurrence 18Leukemia, Myelogenous, Chronic, BCR-ABL Positive 18Ovarian Neoplasms 16Neuroblastoma 16Myeloproliferative Disorders 16Leukemia, Myeloid, Chronic-Phase 16Leukemia, Myeloid, Accelerated Phase 15Congenital Abnormalities 15Neutropenia 13Lung Neoplasms 13

Interventions

Rituximab 6Etoposide 6Cyclophosphamide 5Vincristine 4Prednisone 4Filgrastim 3Doxorubicin 3Radiotherapy 2Procarbazine 2Lomustine 2Cytarabine 2ibritumomab tiuxetan 1efavirenz 1VAP-cyclo protocol 1Radioimmunotherapy 1Peripheral Blood Stem Cell Transplantation 1Mitoguazone 1Methylprednisolone 1Melphalan 1Immunization, Passive 1Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination 1Drug Therapy 1Cisplatin 1Carmustine 1Biological Therapy 1Antibodies, Monoclonal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Lymphoma, AIDS-Related × Filgrastim × Clear all
NCT00006436 2025-12-30

EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
68 enrolled 24 charts
Lymphoid

Acquired Immunodeficiency Syndrome, Neoplasms, Lymphoma, Large B-Cell, Diffuse, Lymphoma, AIDS-Related

NCT00001563 2022-01-19

EPOCH Chemotherapy +/- IL-12 for Previously Untreated and EPOCH Plus Rituximab for Previously Treated Patients With AIDS-Associated Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
39 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, AIDS-Related

NCT00003114 2010-06-11

Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease

Case Comprehensive Cancer Center

Phase 2 Completed
5 enrolled
Lymphoid

Lymphoma, Lymphoma, AIDS-Related

Data powered by HemOnc (CC BY 4.0) Colophon âš¡